United States set
language
Menu Shopping cart $0 Search

Calretinin (29 kDa calbindin)

For some time now, the production and application of asbestos has been banned in more than 55 countries in the world. However, the number of asbestos-associated cancers – mainly malignant lung cancer and mesothelioma – is still high. Due to long latency of the disease and ongoing production and application of asbestos in several countries, no substantial improvement is expected. Detecting tumors early – preferably at stages without clinical symptoms - might improve the chances for a curative therapy. In collaboration with scientists of the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance – Institute of the Ruhr-University Bochum (IPA) the DLD Diagnostika GmbH developed a promising method based on calretinin as a biomarker for early detection – especially of mesothelioma – in plasma and serum samples. Currently, calretinin is one of the best available markers for the detection of mesothelioma.

0 result found